Status:
UNKNOWN
Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis
Lead Sponsor:
University of Leipzig
Conditions:
Coronary Stenosis
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Recent technical advances in percutaneous coronary interventions have made it possible to approach patients with coronary lesions formerly considered to be classical candidates for bypass surgery, e.g...
Detailed Description
Recent technical advances in percutaneous coronary interventions have made it possible to approach patients with coronary lesions formerly considered to be classical candidates for bypass surgery, e.g...
Eligibility Criteria
Inclusion
- Significant left main coronary stenosis \>= 50%
Exclusion
- Acute myocardial infarction (STEMI \< 48h)
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00176397
Start Date
August 1 2003
Last Update
September 10 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Leipzig, Heart Center
Leipzig, Saxony, Germany, 04289